Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

被引:91
作者
Qureshi, M. Muddasir
Hayden, Douglas
Urbinelli, Leo
Ferrante, Kimberly
Newhall, Kristyn
Myers, Daniela
Hilgenberg, Sarah
Smart, Ryan
Brown, Robert H., Jr.
Cudkowicz, Merit E.
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurol Clin Trials Unit, Boston, MA USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Biostat Ctr, Boston, MA USA
[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Boston, MA USA
来源
AMYOTROPHIC LATERAL SCLEROSIS | 2006年 / 7卷 / 03期
关键词
amyotrophic lateral sclerosis; motor neuron disease; epidemiology; risk factors; disease progression;
D O I
10.1080/14660820600640596
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We conducted case-control and prospective longitudinal studies to examine risk factors and predictors of disease progression for ALS. Ninety-five subjects with ALS and 106 healthy control subjects were enrolled. All subjects completed a risk factor questionnaire at enrollment. The ALS subjects were prospectively followed for one year to define factors that influence the rate of disease progression, measured by rate of change in percent predicted forced vital capacity (%FVC) and the ALS functional rating scale (ALSFRS) score. The association of each potential risk factor with ALS was determined using univariate logistic regression. A random slope model was used to determine the association of each risk factor with disease progression. The demographic characteristics of ALS subjects and controls at enrollment did not differ. Significant risk factors for ALS included reported exposure to lead (p=0.02) and pesticides (p=0.03). Disease progression was faster in the ALS subjects having bulbar onset and a shorter time period between onset of symptoms and diagnosis. Pertinent variables not associated with either causation or progression of ALS included physical activity, cigarette smoking and a history of physical trauma or other clinical disorders.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 91 条
[1]  
[Anonymous], 2002, ANAL LONGITUDINAL DA
[2]   A RATING-SCALE FOR AMYOTROPHIC-LATERAL-SCLEROSIS - DESCRIPTION AND PRELIMINARY EXPERIENCE [J].
APPEL, V ;
STEWART, SS ;
SMITH, G ;
APPEL, SH .
ANNALS OF NEUROLOGY, 1987, 22 (03) :328-333
[3]   An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis [J].
Armon, C .
NEUROEPIDEMIOLOGY, 2003, 22 (04) :217-228
[4]  
Armon C, 2000, MUSCLE NERVE, V23, P874, DOI 10.1002/(SICI)1097-4598(200006)23:6<874::AID-MUS5>3.0.CO
[5]  
2-U
[6]   Environmental risk factors for amyotrophic lateral sclerosis [J].
Armon, C .
NEUROEPIDEMIOLOGY, 2001, 20 (01) :2-6
[7]   EPIDEMIOLOGIC CORRELATES OF SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ARMON, C ;
KURLAND, LT ;
DAUBE, JR ;
OBRIEN, PC .
NEUROLOGY, 1991, 41 (07) :1077-1084
[8]  
Armon C., 2003, MOTOR NEURON DISORDE, P167
[9]   Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis [J].
Bachus, R ;
Neubert, K ;
Roots, I ;
Prudlo, J ;
Brockmöller, J ;
Ludolph, AC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (08) :1161-1161
[10]  
Brooks Benjamin Rix, 1994, P131